Hormonal contraception in overweight or obese women
123 results
1 - 100
Hormonal contraceptives for contraception in overweight or obese women
Hormonal contraception in overweight or obese women - Overweight in pregnancy
- Contraception in patients with systemic diseases
Levonorgestrel is ineffective emergency contraception for obese women- Hormonal contraception for women exposed to HIV infection: Cochrane systematic review
- Women who use levonorgestrel-releasing intrauterine devices are less likely to develop ischemic stroke than nonusers of hormonal contraception
- Risk of ischaemic stroke in persons with migraine without aura using combined hormonal contraception
- Certain hormonal contraceptives increase thromboembolism risk when taken with NSAIDs
- Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus
- Copper containing intra‐uterine devices versus depot progestogens for contraception
- Contraception: initiation, choice of method and follow-up
- Strategies to improve adherence and continuation of shorter‐term hormonal methods of contraception
- Immediate start of hormonal contraceptives for contraception
- Combined hormonal versus non-hormonal versus progestin-only contraception in lactation
- Hormonal and intrauterine methods for contraception for women aged 25 years and younger
- Hormonal contraception for women at risk of HIV infection
- Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception
- Steroid hormones for contraception in women with sickle cell disease
- 20 mcg versus over 20 mcg estrogen combined oral contraceptives for contraception
- Repeated use of pre‐ and postcoital hormonal contraception for prevention of pregnancy
- Combined hormonal versus nonhormonal versus progestin‐only contraception in lactation
- Acne
- Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception
- Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
- Fertility returns within 6 months for more than 50% of the women who stop using contraceptives
- Combined oral contraceptives and bone mineral density
- Subdermal implants for contraception
- Combined hormonal contraceptives for heavy menstrual bleeding
- Risk of venous thrombosis in users of 3rd vs. 2nd generation combined oral contraceptives
- Risk of ischaemic stroke in people with migraine with aura
- Interventions to improve contraception use
- Abnormal menstrual bleeding
- Combined oral contraceptives for heavy menstrual bleeding
- Oral contraceptives and the risk of ovarian cancer
- Risk of venous thromboembolism in users of combined contraceptives
- Hormonal contraception
- Oral contraceptives in the treatment of endometriosis
- Modern hormonal contraception associated with increased risk of breast cancer
- Ischaemic stroke and myocardial infarction risk with combined oral contraceptives
- Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception.
- Progestogen‐releasing intrauterine systems versus other forms of reversible contraceptives for contraception
- Progestins for symptomatic treatment of endometriosis
- Intrauterine device
- Breast cancer and hormonal contraceptives
- Progestin‐only contraceptives: effects on weight
- Combination contraceptives: effects on weight
- Behavioral interventions for improving dual-method contraceptive use: Cochrane systematic review
- Levonorgestrel intrauterine system vs. other forms of reversible contraceptives
- Progestin intrauterine devices versus copper intrauterine devices for emergency contraception
- Secondary hypertension
- Combination injectable contraceptives for contraception
- Continuous or extended cycle use of combined oral contraceptives
- Oestrogens and progestins for preventing and treating postpartum depression: Cochrane systematic review
- Steroidal contraceptives and bone fractures in women: evidence from observational studies
- Triphasic versus monophasic oral contraceptives for contraception: Cochrane systematic review
- Risk of myocardial infarction in users of third generation oral contraceptives
- Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods for preventing pregnancy
- Steroid hormones for contraception in men
- OC use associated with reduction in ovarian cancer risk